LON:GSK - GlaxoSmithKline News Headlines

Sign in or create an account to add this stock to your watchlist.
GBX 1,555 +5.00 (+0.32 %)
(As of 05/19/2019 04:00 PM ET)
Previous CloseGBX 1,555
Today's RangeGBX 1,536.80 - GBX 1,557.80
52-Week RangeGBX 1,408.80 - GBX 1,648.80
Volume21.38 million shs
Average Volume9.12 million shs
Market Capitalization£76.93 billion
P/E Ratio19.81
Dividend Yield5.85%
BetaN/A

Headlines

GlaxoSmithKline (LON GSK) News Headlines

Source:
DateHeadline
3 FTSE 100 dividend stocks paying more than GlaxoSmithKline3 FTSE 100 dividend stocks paying more than GlaxoSmithKline
uk.finance.yahoo.com - May 18 at 8:58 AM
Global Influenza Vaccines Markets 2019-2025 - Sanofi Pasteur, GSK, Seqirus and AstraZeneca are the Key Market InfluencersGlobal Influenza Vaccines Markets 2019-2025 - Sanofi Pasteur, GSK, Seqirus and AstraZeneca are the Key Market Influencers
finance.yahoo.com - May 18 at 8:58 AM
GSK and Novartis liniment marketing misled Australian consumers: courtGSK and Novartis liniment marketing misled Australian consumers: court
www.reuters.com - May 18 at 8:58 AM
Thermo Fisher Scientific (TMO) Acquires Manufacturing Site in Cork, Ireland from GlaxoSmithKline (GSK) for EUR90M in Cash - StreetInsider.comThermo Fisher Scientific (TMO) Acquires Manufacturing Site in Cork, Ireland from GlaxoSmithKline (GSK) for EUR90M in Cash - StreetInsider.com
www.streetinsider.com - May 17 at 8:28 AM
Trade rhetoric weighs on European sharesTrade rhetoric weighs on European shares
finance.yahoo.com - May 17 at 8:28 AM
GlaxoSmithKlines (GSK) Neutral Rating Reiterated at UBS GroupGlaxoSmithKline's (GSK) Neutral Rating Reiterated at UBS Group
www.americanbankingnews.com - May 17 at 6:33 AM
Edited Transcript of GSKCONS.NSE earnings conference call or presentation 13-May-19 6:30am GMT - Yahoo FinanceEdited Transcript of GSKCONS.NSE earnings conference call or presentation 13-May-19 6:30am GMT - Yahoo Finance
finance.yahoo.com - May 14 at 8:48 AM
Stanford Dad Accused of $6.5 Million Payment in College Scandal Has a New ProblemStanford Dad Accused of $6.5 Million Payment in College Scandal Has a New Problem
finance.yahoo.com - May 14 at 8:48 AM
GlaxoSmithKline (GSK) Earns Buy Rating from HSBCGlaxoSmithKline (GSK) Earns Buy Rating from HSBC
www.americanbankingnews.com - May 14 at 6:15 AM
GlaxoSmithKline plc (GSK) Insider Acquires £136.08 in StockGlaxoSmithKline plc (GSK) Insider Acquires £136.08 in Stock
www.americanbankingnews.com - May 14 at 2:08 AM
Global Asthma & COPD Therapeutics Market to 2025: Focus on Bronchodilator Monotherapy - Featuring AstraZeneca, GlaxoSmithKline, F. Hoffmann-La Roche, Novartis, and Merck & Co - PRNewswireGlobal Asthma & COPD Therapeutics Market to 2025: Focus on Bronchodilator Monotherapy - Featuring AstraZeneca, GlaxoSmithKline, F. Hoffmann-La Roche, Novartis, and Merck & Co - PRNewswire
www.prnewswire.com - May 13 at 8:25 AM
GSK Consumer Healthcare Q4 profit up 35 per cent to Rs 285 croreGSK Consumer Healthcare Q4 profit up 35 per cent to Rs 285 crore
www.msn.com - May 11 at 8:31 AM
GlaxoSmithKline plc (GSK) Receives Consensus Recommendation of "Hold" from AnalystsGlaxoSmithKline plc (GSK) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 11 at 2:07 AM
GSK-Pfizer deal gets approval from Australias anti-trust watchdogGSK-Pfizer deal gets approval from Australia's anti-trust watchdog
finance.yahoo.com - May 9 at 8:29 AM
Comparing the EPS Growth Trajectories of PFE and GSKComparing the EPS Growth Trajectories of PFE and GSK
finance.yahoo.com - May 8 at 8:30 AM
What Are Analysts Recommending for PFE and GSK in May?What Are Analysts Recommending for PFE and GSK in May?
finance.yahoo.com - May 7 at 6:53 PM
Deutsche Bank Reiterates Hold Rating for GlaxoSmithKline (GSK)Deutsche Bank Reiterates Hold Rating for GlaxoSmithKline (GSK)
www.americanbankingnews.com - May 3 at 6:51 AM
Credit Suisse Group Analysts Give GlaxoSmithKline (GSK) a GBX 1,600 Price TargetCredit Suisse Group Analysts Give GlaxoSmithKline (GSK) a GBX 1,600 Price Target
www.americanbankingnews.com - May 2 at 12:05 PM
GlaxoSmithKlines (GSK) "Hold" Rating Reaffirmed at Deutsche BankGlaxoSmithKline's (GSK) "Hold" Rating Reaffirmed at Deutsche Bank
www.americanbankingnews.com - May 2 at 10:13 AM
GlaxoSmithKline (GSK) Price Target Cut to GBX 1,660GlaxoSmithKline (GSK) Price Target Cut to GBX 1,660
www.americanbankingnews.com - May 2 at 9:55 AM
Shore Capital Reaffirms "Hold" Rating for GlaxoSmithKline (GSK)Shore Capital Reaffirms "Hold" Rating for GlaxoSmithKline (GSK)
www.americanbankingnews.com - May 2 at 9:55 AM
Insider Buying: GlaxoSmithKline plc (GSK) Insider Buys 458 Shares of StockInsider Buying: GlaxoSmithKline plc (GSK) Insider Buys 458 Shares of Stock
www.americanbankingnews.com - May 2 at 9:41 AM
GlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript - Yahoo FinanceGlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - May 2 at 8:33 AM
Edited Transcript of GSK.L earnings conference call or presentation 1-May-19 1:00pm GMTEdited Transcript of GSK.L earnings conference call or presentation 1-May-19 1:00pm GMT
finance.yahoo.com - May 2 at 8:33 AM
GlaxoSmithKlines (GSK) "Neutral" Rating Reiterated at UBS GroupGlaxoSmithKline's (GSK) "Neutral" Rating Reiterated at UBS Group
www.americanbankingnews.com - May 2 at 8:29 AM
GlaxoSmithKline plc (GSK) Plans Dividend of GBX 19GlaxoSmithKline plc (GSK) Plans Dividend of GBX 19
www.americanbankingnews.com - May 1 at 7:46 PM
GlaxoSmithKline plc (GSK) Q1 2019 Earnings Call TranscriptGlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 1 at 7:22 PM
GlaxoSmithKline (GSK) PT Set at GBX 1,900 by Goldman Sachs GroupGlaxoSmithKline (GSK) PT Set at GBX 1,900 by Goldman Sachs Group
www.americanbankingnews.com - May 1 at 12:49 PM
TOP NEWS: Vaccine Sales Jump-Start GlaxoSmithKline First Quarter - MorningstarTOP NEWS: Vaccine Sales Jump-Start GlaxoSmithKline First Quarter - Morningstar
www.morningstar.co.uk - May 1 at 8:24 AM
GlaxoSmithKline plc 2019 Q1 - Results - Earnings Call Slides - Seeking AlphaGlaxoSmithKline plc 2019 Q1 - Results - Earnings Call Slides - Seeking Alpha
seekingalpha.com - May 1 at 8:24 AM
GlaxoSmithKline declares GBP 0.19 dividend - Seeking AlphaGlaxoSmithKline declares GBP 0.19 dividend - Seeking Alpha
seekingalpha.com - May 1 at 8:24 AM
Shingles and HIV medications boost GSK first quarter salesShingles and HIV medications boost GSK first quarter sales
finance.yahoo.com - May 1 at 8:24 AM
GSK first-quarter beats estimates on shingles vaccine surgeGSK first-quarter beats estimates on shingles vaccine surge
finance.yahoo.com - May 1 at 8:24 AM
Global Osteoarthritis Therapeutics Market 2019-2023: Market will Register a CAGR of about 8% - Key Vendors are Bayer, GlaxoSmithKline, Johnson & Johnson, Pfizer, & Sanofi - PRNewswireGlobal Osteoarthritis Therapeutics Market 2019-2023: Market will Register a CAGR of about 8% - Key Vendors are Bayer, GlaxoSmithKline, Johnson & Johnson, Pfizer, & Sanofi - PRNewswire
www.prnewswire.com - April 29 at 8:24 AM
ViiV files U.S. application for two-drug combo for HIV - Seeking AlphaViiV files U.S. application for two-drug combo for HIV - Seeking Alpha
seekingalpha.com - April 29 at 8:24 AM
GSKs HIV drug wins European panel thumbs-upGSK's HIV drug wins European panel thumbs-up
finance.yahoo.com - April 26 at 6:51 PM
GlaxoSmithKlines (GSK) Neutral Rating Reiterated at Credit Suisse GroupGlaxoSmithKline's (GSK) Neutral Rating Reiterated at Credit Suisse Group
www.americanbankingnews.com - April 25 at 8:39 AM
GlaxoSmithKline: U.K. Pound Performance Review For U.K. Investors - Seeking AlphaGlaxoSmithKline: U.K. Pound Performance Review For U.K. Investors - Seeking Alpha
seekingalpha.com - April 24 at 8:28 AM
COPD space about to have another drug — this time from a Morrisville concernCOPD space about to have another drug — this time from a Morrisville concern
finance.yahoo.com - April 18 at 8:30 AM
Mumps - Pipeline Review, H1 2019 Featuring Cadila Healthcare, GlaxoSmithKline and Sinovac Biotech - ResearchAndMarkets.com - Business WireMumps - Pipeline Review, H1 2019 Featuring Cadila Healthcare, GlaxoSmithKline and Sinovac Biotech - ResearchAndMarkets.com - Business Wire
www.businesswire.com - April 17 at 8:29 AM
Don’t Give Up on Gilead Sciences Stock After GlaxoSmithKline Beat It to a New HIV Drug - BarronsDon’t Give Up on Gilead Sciences Stock After GlaxoSmithKline Beat It to a New HIV Drug - Barron's
www.barrons.com - April 9 at 10:05 PM
Don’t Give Up on Gilead Stock After GlaxoSmithKline Beat It to a New HIV Drug, Analyst SaysDon’t Give Up on Gilead Stock After GlaxoSmithKline Beat It to a New HIV Drug, Analyst Says
finance.yahoo.com - April 9 at 10:05 PM
GlaxoSmithKline Notes Approval Of HIV Drug Dovato In US - MorningstarGlaxoSmithKline Notes Approval Of HIV Drug Dovato In US - Morningstar
www.morningstar.co.uk - April 9 at 8:41 AM
PRESS DIGEST- Financial Times - April 9PRESS DIGEST- Financial Times - April 9
finance.yahoo.com - April 9 at 8:41 AM
ViiV Healthcares Juluca shows sustained treatment effect in studies - Seeking AlphaViiV Healthcare's Juluca shows sustained treatment effect in studies - Seeking Alpha
seekingalpha.com - April 3 at 8:38 AM
GSK Finance Chief Hands Baton to Successor as Centralization Efforts Bear Fruit - The Wall Street JournalGSK Finance Chief Hands Baton to Successor as Centralization Efforts Bear Fruit - The Wall Street Journal
www.wsj.com - April 2 at 9:35 PM
Form 6-K GLAXOSMITHKLINE PLC For: Apr 02 - StreetInsider.comForm 6-K GLAXOSMITHKLINE PLC For: Apr 02 - StreetInsider.com
www.streetinsider.com - April 2 at 8:54 AM
Pfizer spinout SpringWorks nets $125 million from VCs, GlaxoSmithKline - New York Business JournalPfizer spinout SpringWorks nets $125 million from VCs, GlaxoSmithKline - New York Business Journal
www.bizjournals.com - April 1 at 7:50 PM
Is GlaxoSmithKline’s 5% dividend yield safe? - Yahoo Finance UKIs GlaxoSmithKline’s 5% dividend yield safe? - Yahoo Finance UK
uk.finance.yahoo.com - March 30 at 8:26 AM
The Brexit Day That Wasn't Leaves Britain Counting the CostThe Brexit Day That Wasn't Leaves Britain Counting the Cost
finance.yahoo.com - March 29 at 8:36 AM
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: What is Forex?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel